Latest News
Kura Oncology, Inc.
- Kura Oncology, Inc. Estimates – HAM:KUR
- Kura Oncology launches clinical study for farnesyl transferase inhibitor combination therapy
- KURA Q3'26 Earnings: revenue estimate is 24.86M USD
- Kura Oncology, Inc. (KURA) Discusses KO-7246 Data and Development Strategy for Menin Inhibitors in Diabetes - Slideshow (NASDAQ:KURA) 2026-10-13
- Caspian Therapeutics and Kura Oncology to host investor call By Investing.com
- Caspian Therapeutics and Kura Oncology to Host Investor
- Kura Oncology stock seen rising on leukemia drug sales and pipeline potential
- JPMorgan initiates Kura Oncology stock with overweight rating
- Kura Oncology chief legal officer sells $88,618 in shares
- Form 144 KURA ONCOLOGY For: 28 September By Investing.com
- Kura Oncology COO Kathleen Ford sells $111,930 in company stock
- Kura Oncology SVP sells $48,360 of stock
Headlines from the last 30 days, linking to the original publishers. See all market news →